drug:wegovy

Wegovy in pill form is coming

Novo Nordisk is producing a pill form of Wegovy -- the only pill to be FDA approved (if/when it is) for weight loss.

GLP1.Guide Staff

GLP1.Guide Staff

— 2 min read
Wegovy in pill form is coming

The Wegovy brand is already one of the best selling GLP1 receptor agonists out there:

🍃
Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work?

Check out our quick explainer

Semaglutide is the clinical name for the GLP1 formulation that powers Wegovy, and up until now it's been primarily used as an subcutaneous injection – the injection pens most people use to take their doses:

Wegovy pen illustration

Novo Nordisk, the company behind Wegovy is not preparing to introduce a Wegovy pill – much easier to take and close to the same effectiveness as the injection.

This is a huge development that has made the news, and has holders of Novo Nordisk stock excited:

Novo Nordisk Says Its ‘Wegovy In A Pill’ Delivers Big: ’16.6% Average’ Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity - Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY)
Novo Nordisk A/S (NYSE: NVO) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company highlights early data that shows safety and efficacy figures that are similar to its injectables.
BenzingaVishaal Sanjay
Novo’s Wegovy Inches Closer to Becoming First FDA-Approved GLP-1 Weight-Loss Pill
The FDA accepted Novo Nordisk’s NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the drug in the fourth quarter of this year.
BioSpaceTristan Manalac

We went straight to the source (Novo Nordisk) to see what the fuss is about.

What did Novo Nordisk announce?

Rather than a direct Novo Nordisk announcement, this news came by way of an FDA filing...

The rest of this article is no longer available for free – if you'd like to read the rest of our analysis, check us out on Substack:

Read the rest on Substack

Read more